戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              DC-SIGN (dendritic cell-specific intercellular adhesion
2                                              DC-SIGN (SIGN-R1) is present on mouse lung epithelial ce
3                                              DC-SIGN also was shown to play a role in the infection o
4                                              DC-SIGN and CD206 nanodomains are randomly distributed o
5                                              DC-SIGN efficiently reduces the amount of gp120 present
6                                              DC-SIGN forms remarkably stable microdomains on the plas
7                                              DC-SIGN has high affinity for fucosylated glycans in sev
8                                              DC-SIGN is a dendritic cell surface structure which part
9                                              DC-SIGN is a major receptor for infection of both monocy
10                                              DC-SIGN is thought to be crucial for the development of
11                                              DC-SIGN nanoclusters exhibited free, Brownian diffusion
12                                              DC-SIGN, a Ca(2+)-dependent transmembrane lectin, is fou
13                                              DC-SIGN-blocking assays were performed by incubating DCs
14                                              DC-SIGN-targeted transduction occurs in the presence of
15  frequency and microbiome of CD19(-)BDCA-1(+)DC-SIGN(+) blood myeloid DCs (mDCs) were analyzed in CP
16            We found that cocaine activates a DC-SIGN mediated 'signalosome' complex by enhancing its
17 tition than gp120 that was not prebound in a DC-SIGN cell surface binding assay.
18 tion and decreased T cell proliferation in a DC-SIGN-, glycosylation-, and Raf1-dependent manner.
19 alpha, production by LPS-stimulated DCs in a DC-SIGN-dependent fashion.
20 tDNA, which induces platelet activation in a DC-SIGN-dependent manner.
21            Finally, M2 macrophages induced a DC-SIGN-dependent adhesion of highly mannosylated IgM(+)
22  mtDNA induces platelet activation through a DC-SIGN dependent pathway.
23                                      Using a DC-SIGN-Fc chimera, food extracts were tested for bindin
24          Our data suggest that SAP activates DC-SIGN to regulate the innate immune system differently
25                                 In addition, DC-SIGN expression was sufficient to cause a significant
26                                 In addition, DC-SIGN-mediated endocytosis provided a minor alternativ
27                   A polycyclic aminothiazole DC-SIGN ligand and anti-DC-SIGN antibodies mimic SAP eff
28 nnose, Fc receptor, CD11c/CD 18, DEC-205 and DC-SIGN on DC for active targeting is reviewed.
29  inhibiting gp120 interactions with 2G12 and DC-SIGN and blocking 2G12-mediated neutralization of HIV
30 characterize their interaction with 2G12 and DC-SIGN by a glycan microarray binding assay.
31 icrobicide should target both syndecan-3 and DC-SIGN on DCs to prevent transmission.
32     Thus, HIV-1 exploits both syndecan-3 and DC-SIGN to mediate HIV-1 transmission, and an effective
33            Antibodies specific for SR-BI and DC-SIGN/L-SIGN reduced B-cell transinfection, supporting
34 g antibodies against CD18, CD11a, CD11b, and DC-SIGN as well as TLR4.
35 nd CD68 expression), polarization (CD206 and DC-SIGN expression), and IL-10 secretion.
36 f HCV-induced CD68 and M2 markers (CD206 and DC-SIGN) in normal monocytes was further enhanced in the
37 mong the inflammatory markers, only CD68 and DC-SIGN were significant prognostic factors in univariat
38 nhibitory receptors (FcRL5, FcgammaRIIb, and DC-SIGN) with high avidity and specificity, whilst elimi
39  cell line decreases PU.1 protein levels and DC-SIGN at both the mRNA and protein levels.
40 ity to invade DCs, alveolar macrophages, and DC-SIGN-expressing transfectants.
41 yte-derived DCs (Mo-DCs) develop in mice and DC-SIGN/CD209a marks the cells.
42 ifically to the lectin domains of the MR and DC-SIGN and blocked signaling.
43 s indicate that the CRDs of both SIGN-R1 and DC-SIGN bind to a restricted set of primarily oligomanno
44        Mutations in dectin-1 (rs7309123) and DC-SIGN (rs11465384 and rs7248637), allogeneic stem cell
45     The genes encoding OAS1, OAS2, TLR3, and DC-SIGN, which mediate antiviral innate immunity, were w
46                                         Anti-DC-SIGN monoclonal antibody (MAb) inhibited HHV-8 infect
47 cyclic aminothiazole DC-SIGN ligand and anti-DC-SIGN antibodies mimic SAP effects in vitro.
48 ceptors because only the combination of anti-DC-SIGN and low-molecular-weight heparin prevented bindi
49 blocked, in part, by Raf-1 inhibitor or anti-DC-SIGN antibodies and was significantly reduced in cell
50 food extracts followed by staining with anti-DC-SIGN antibody.
51  of HIV-1 attachment factors (HAFs), such as DC-SIGN, heparan sulfate proteoglycan (HSPG), and alpha4
52 es can be mediated by C-type lectins such as DC-SIGN.
53 DC-SIGN and DC-SIGNR (collectively termed as DC-SIGN/R) using a sensitive, ratiometric Forster resona
54 oprotein from Sindbis virus engineered to be DC-SIGN-specific.
55        To understand the differences between DC-SIGN and L-SIGN that affect HIV-1 interactions, we de
56 polymers to inhibit the interactions between DC-SIGN and the HIV envelope glycoprotein gp120.
57         In THP-1 cells and human MDDCs, BG60-DC-SIGN interaction led to the activation of Raf-1 and E
58              The QD probes specifically bind DC-SIGN, but not its closely related receptor DC-SIGNR,
59 of glycomimetic compounds were able to block DC-SIGN-dependent HIV infection in cervical explant mode
60                                     Blocking DC-SIGN signaling allows RLR activation and suppresses M
61                                     Blocking DC-SIGN with HIV-1 gp120 prevents the uptake of minor fi
62       However, combination targeting to both DC-SIGN and BDCA3(+) DCs led to significantly greater ac
63 led to endocytosis in vitro as expected, but DC-SIGN, even when cross-linked, did not lead to signifi
64  further intracellular pathways activated by DC-SIGN in a range of primary FL cells with detection of
65                                Activation by DC-SIGN occurred in both IgM(+) and IgG(+) cases and led
66 udding is due to internalization of gp120 by DC-SIGN.
67 t internalization of virus-like particles by DC-SIGN.
68 rom DCs to T cells was mediated primarily by DC-SIGN.
69 alled MDDC differentiation, as quantified by DC-SIGN/CD14 expression ratios, showing cooperative invo
70 ht differences between pathogen targeting by DC-SIGN and receptors in which binding sites at fixed sp
71 ing factor (M-CSF)-dependent, CD14(+)CD11b(+)DC-SIGN(+) monocyte-derived DCs.
72 eclampsia, both CD14(+)DC-SIGN(+) and CD14(+)DC-SIGN(-) APCs induced iTreg cells poorly.
73     Conversely, in preeclampsia, both CD14(+)DC-SIGN(+) and CD14(+)DC-SIGN(-) APCs induced iTreg cell
74                 We show that decidual CD14(+)DC-SIGN(+) APCs are closely associated with Foxp3(+) Tre
75   These results suggest that decidual CD14(+)DC-SIGN(+) APCs may play important roles in iTreg cell i
76                          Furthermore, CD14(+)DC-SIGN(+) cells display a distinct phenotype compared w
77 s significantly more efficiently than CD14(+)DC-SIGN(-) APCs.
78 istinct phenotype compared with their CD14(+)DC-SIGN(-) counterparts.
79                             In vitro, CD14(+)DC-SIGN(+) APCs from healthy pregnant women induced iTre
80  there is a complete deficiency of CD209(+) (DC-SIGN) human dendritic cells.
81  CD206/macrophage mannose receptor and CD209/DC-SIGN, as well as costimulatory molecules CD86 and CD4
82 -SIGN (CD209) or its isoform L-SIGN (CD299) (DC-SIGN/R).
83 HIV-1 gp120-specific attachment factors CD4, DC-SIGN, and syndecans, were attenuated in their ability
84 s of DCs is based on the expression of CD83, DC-SIGN, and DC-LAMP, which are nonspecific markers of D
85                    We sought to characterize DC-SIGN-binding glycoproteins in a panel of allergenic a
86                             On the contrary, DC-SIGN enhances HIV trans-infection of T lymphocytes.
87 e 2 is the functional receptor for SARS-CoV; DC-SIGN and CD209L (L-SIGN) can enhance viral entry.
88  lack of the expression of CD4, CCR5, CXCR4, DC-SIGN, or mannose receptors in tubular cells.
89           Both BDCA3(+) and monocyte-derived DC-SIGN(+) NP-loaded DCs were equally effective at gener
90 loped Raji B cell lines expressing different DC-SIGN/L-SIGN chimeras.
91 ing of gp120 to 2G12 and recombinant dimeric DC-SIGN with IC(50) in the nanomolar range.
92 irus bearing 134mut exhibited less efficient DC-SIGN-mediated infection in trans.
93 core LPS is naturally exposed, might exploit DC-SIGN to invade APCs.
94                      Dendritic cells express DC-SIGN, a C-type lectin (CTL) that binds a variety of p
95 ut not in B-cell lines transduced to express DC-SIGN lacking the transmembrane domain, demonstrating
96 es from peripheral blood and tonsils express DC-SIGN and that this expression increases after B-cell
97 dendritic cells (DCs), many of which express DC-SIGN (DC-specific ICAM-3 grabbing nonintegrin; CD209)
98  of feline monocyte-derived cells expressing DC-SIGN, indicating a role for FIPV infection in vivo.
99       Although human B cell lines expressing DC-SIGN efficiently capture and transmit HIV-1 to suscep
100 ood myeloid DCs, and B-cell lines expressing DC-SIGN.
101 D) displayed the highest binding avidity for DC-SIGN.
102                   Thus, selectivity gain for DC-SIGN versus langerin is observed with pseudo-1,2-mann
103 minor peanut allergen, is a novel ligand for DC-SIGN.
104 ligomannose glycans are also the ligands for DC-SIGN, a C-type lectin found on the surface of dendrit
105 ssentially undetectable lateral mobility for DC-SIGN but an appreciable mobility for HA within their
106 ange similar to that previously observed for DC-SIGN.
107 ereas oligomannose-type glycans required for DC-SIGN-dependent cellular attachment are predominant on
108 ther, our data support an important role for DC-SIGN-expressing infiltrating cells in the biology of
109 described for Lewis X, a ligand specific for DC-SIGN among the C-type lectin family.
110 ment of the cells with antibody specific for DC-SIGN or with mannan but not antibody specific for xCT
111  high-resolution structure of a glycomimetic/DC-SIGN complex by X-ray crystallography.
112 which are CD11b(+)F4/80(+)CD11c(+)MHCII(high)DC-SIGN(high)Ly6c(+) and express high levels of CCR5, CX
113 ls can be rescued by the expression of human DC-SIGN (hDC-SIGN) and that infection of a permissive fe
114                  This study shows that human DC-SIGN is a receptor for Y. pestis that promotes phagoc
115  (LPS) as ligands to interact with the human DC-SIGN.
116      In this study, stably transfected human DC-SIGN(+/-) Raji cell lines and monocyte-derived DCs (M
117 taining glycopolymers to interact with human DC-SIGN and the ability of these glycopolymers to inhibi
118 and can be restored by a knock-in with human DC-SIGN.
119 s response in detail, we generated humanized DC-SIGN mice (hDC-SIGN), and demonstrate that the anti-i
120               Using retagging, we identified DC-SIGN as a novel receptor involved in the initial reco
121 fects of costimulatory blockade and identify DC-SIGN(+) suppressive macrophages as crucial mediators
122                                 Importantly, DC-SIGN nanocluster dissolution exclusively compromised
123 ests how CRDs may be disposed differently in DC-SIGN compared with DC-SIGNR and in variant forms of D
124  C-terminal C-type CRDs, the neck domains in DC-SIGN and DC-SIGNR act as autonomous tetramerization d
125 s of the carbohydrate-recognition domains in DC-SIGN and DC-SIGNR result from variations in the seque
126 Further, LARG was observed to participate in DC-SIGN mediated internalization of HIV-1 in DCs.
127           Comparison of the binding sites in DC-SIGN and langerin, two other pathogen-binding recepto
128  used gene silencing to specifically inhibit DC-SIGN expression by DCs followed by allergen uptake st
129           Thus, approaches aiming to inhibit DC-SIGN, without blocking langerin, represent attractive
130 DC-specific ICAM-3 -: grabbing non integrin (DC-SIGN) and macrophage mannose receptor 1 (MMR-1).
131  to DC-specific ICAM3-grabbing non-integrin (DC-SIGN) and its related receptor, L-SIGN, were found.
132 r adhesion molecule-3 grabbing non-integrin (DC-SIGN) and mannose receptor, bound to FL surface immun
133 r adhesion molecule-3-grabbing non-integrin (DC-SIGN) on DCs as early as day 2 and continuing through
134 r adhesion molecule-3 grabbing non-integrin (DC-SIGN), after directly targeting the transcription fac
135 r adhesion molecule-3-Grabbing Non-integrin (DC-SIGN), CD123, neutrophil elastase, CD31, and carbonic
136 -cell-specific ICAM-3 grabbing non-integrin (DC-SIGN; also known as CD209).
137                               Interestingly, DC-SIGN was found within the FL cell niche in situ.
138 by the internalization of P. gingivalis into DC-SIGN-rich intracellular compartments, and MoDCs secre
139 ore, we asked whether RSV infection involves DC-SIGN (CD209) or its isoform L-SIGN (CD299) (DC-SIGN/R
140  of the feline homologue to the human lectin DC-SIGN and show that it is a coreceptor for virulent st
141 tion domain (CRD) of the cell-surface lectin DC-SIGN (dendritic cell-specific intercellular adhesion
142 ty binding to the human transmembrane lectin DC-SIGN and act as inhibitors to prevent the binding of
143 G-I and Mda5 by activating the C-type lectin DC-SIGN and inducing signaling that prevents RLR dephosp
144                            The C-type lectin DC-SIGN expressed on dendritic cells (DCs) facilitates c
145 en a human dendritic cell associated lectin (DC-SIGN) and the viral envelope glycoprotein gp120.
146  blocked viral binding to the C-type lectin, DC-SIGN.
147 eceptors CD81, SR-BI, and the C-type lectins DC-SIGN and L-SIGN.
148 rmore, CV-N competed with the C-type lectins DC-SIGN and mannose receptor for ligand binding and inhi
149 l, SARS-CoV is thought to use C-type lectins DC-SIGN and/or L-SIGN (collectively referred to as DC/L-
150 cell lines transduced to express full-length DC-SIGN but not in B-cell lines transduced to express DC
151 ld be involved in targeting or cross-linking DC-SIGN.
152 studies using Fc chimeras revealed that LRP, DC-SIGN, and mannose receptor can bind to FVIII; however
153 s in the healthy human brain through the MOG-DC-SIGN homeostatic regulatory axis, which is comprised
154 ular adhesion molecule-grabbing nonintegrin (DC-SIGN) (CD209) receptor, expressed by APCs, to be capt
155 ar adhesion molecule-3-grabbing nonintegrin (DC-SIGN) and heparan sulfate proteoglycan were implicate
156 ar adhesion molecule 3-grabbing nonintegrin (DC-SIGN) and the macrophage galactose lectin, to glycopr
157 ion molecule 3 (ICAM3) grabbing nonintegrin (DC-SIGN) leads to a reduction in the expression of Toll-
158 hesion molecule type-3-grabbing nonintegrin (DC-SIGN) level in aged DCs.
159 c cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN) necessary for human immunodeficiency virus, typ
160 ar adhesion molecule-3-grabbing nonintegrin (DC-SIGN) on microglia and DCs.
161 on molecule-3 (ICAM-3)-grabbing nonintegrin (DC-SIGN) with respect to retrovirus binding.
162 c cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN), and TLR4 because ActApo-induced up-regulation
163 c cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN), mannose-binding lectin, and heparan sulfate, e
164 ar adhesion molecule-3-grabbing nonintegrin (DC-SIGN), which could in turn trigger delayed but long-l
165 ar adhesion molecule-3-grabbing nonintegrin (DC-SIGN).
166 ar adhesion molecule-3-grabbing nonintegrin (DC-SIGN).
167 ar adhesion molecule 3-grabbing nonintegrin (DC-SIGN).
168 ar adhesion molecule-3-grabbing nonintegrin (DC-SIGN)/CD23, are increased.
169 c cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN, CD209), Dectin-1, Toll-like receptors (TLRs), c
170 hat ES targets DC-specific ICAM nonintegrin (DC-SIGN) to survive in myeloid DCs for which outer membr
171                                   This novel DC-SIGN-T(H)2 pathway initiated by an endogenous ligand,
172 stimulatory blockade favored accumulation of DC-SIGN-expressing macrophages that inhibited CD8(+) T c
173 urther confirmed by its specific blocking of DC-SIGN engagement with the Ebola virus glycoprotein.
174 prehensive report on the characterization of DC-SIGN-binding proteins in common allergenic foods such
175                                  Deletion of DC-SIGN-expressing macrophages in vivo, interfering with
176 ther investigate the lateral distribution of DC-SIGN.
177 ayers displaying the extracellular domain of DC-SIGN and a neoglycolipid bearing an oligosaccharide l
178   In the work reported here, neck domains of DC-SIGN and DC-SIGNR expressed in isolation are shown to
179    ET treatment results in downregulation of DC-SIGN, a marker of immature DCs, and upregulation of D
180 ersely correlated with surface expression of DC-SIGN (DC-specific intercellular adhesion molecule-3-g
181 th HHV-8 resulted in increased expression of DC-SIGN and a decrease in the expression of CD20 and maj
182 rate that cocaine induces over expression of DC-SIGN and significantly enhances virus transfer from D
183                      Thus, the expression of DC-SIGN is essential for productive HHV-8 infection of a
184 in on LC but downregulated the expression of DC-SIGN on iDDC, as we previously reported for MDDC.
185    This profile is enhanced by expression of DC-SIGN on MoDCs and minor mfa-1 fimbriae on P. gingival
186                   The relative expression of DC-SIGN, GLUT-1, HSPGs, and NRP-1 first was examined on
187 s of CD209e (DC-SIGNR4), a murine homolog of DC-SIGN, were increased in the lungs of HDM-challenged V
188   In addition, differences in the lengths of DC-SIGN and DC-SIGNR extracellular domains with equivale
189 eas immature DC, expressing higher levels of DC-SIGN and similar FcgammaRIIa levels, did not undergo
190                                  Location of DC-SIGN in FL tissue revealed high levels in sinusoidlik
191 luence the nanoscale lateral organization of DC-SIGN but restrict the mobility of the receptor to dis
192 he absence of Ca(2+) and by preincubation of DC-SIGN with mannan, suggesting that C1q binds to DC-SIG
193 thrin, thereby increasing the probability of DC-SIGN-clathrin interactions beyond random encountering
194                    Consequently, the role of DC-SIGN and other HTLV-1 attachment factors was analyzed
195                 However, the precise role of DC-SIGN in food allergy pathogenesis is not yet understo
196                  The surprising stability of DC-SIGN microdomains may reflect structural features tha
197 hus, HIV sequestration by and stimulation of DC-SIGN helps HIV evade immune responses and spread to c
198 ains to Raji cells and MoDCs is dependent on DC-SIGN, whereas the double fimbriae mutant strain does
199 n) sites in gp120 that contribute to optimal DC-SIGN binding.
200                         Blocking of MMR-1 or DC-SIGN with neutralizing Abs partially inhibits this ef
201 derived inflammatory DCs such as CD14 and/or DC-SIGN, E-Cadherin, and/or CX3CR1.
202 pressing the interleukin-3 receptor CD123 or DC-SIGN.
203  versatility in entry routes (FcgammaRIIa or DC-SIGN) in mature DC broadens target options and sugges
204 s on the C-type lectin receptor, langerin or DC-SIGN, involved in gp120 interaction.
205 ctin domains of the mannose receptor (MR) or DC-SIGN bind mannosylated Igs in vitro and bind to FL ce
206 iated knockdown of LRP, mannose receptor, or DC-SIGN expression in monocyte-derived dendritic cells d
207 y bind to the dendritic cell-surface protein DC-SIGN.
208 k regions, and receptor diffusion to provide DC-SIGN with the exquisite ability to dock pathogens at
209               A human orthologue of SIGN-R1, DC-SIGN, displays a similar binding specificity to SIGN-
210 f the dendritic cell glycan-binding receptor DC-SIGN and the closely related endothelial cell recepto
211 Targeting of myeloid-dendritic cell receptor DC-SIGN by numerous chronic infectious agents, including
212                  The dendritic cell receptor DC-SIGN mediates pathogen recognition by binding to glyc
213 cell contact and the dendritic cell receptor DC-SIGN.
214  fimbria, targets the C-type lectin receptor DC-SIGN for invasion and persistence within human monocy
215  cells expressing the C-type lectin receptor DC-SIGN, persisted at sites of HSV-2 reactivation for mo
216 12 and PGT123, or the C-type lectin receptor DC-SIGN.
217 port that SAP but not CRP binds the receptor DC-SIGN (SIGN-R1) to affect the innate immune system, an
218 mains (CRDs) in the glycan-binding receptors DC-SIGN (dendritic-cell-specific intercellular adhesion
219 tivalent interactions of HIV/Ebola receptors DC-SIGN and DC-SIGNR (collectively termed as DC-SIGN/R)
220 gens and on mammalian cells by the receptors DC-SIGN (CD209) and DC-SIGNR (L-SIGN, CD299) is dependen
221                 However, soluble recombinant DC-SIGN was shown to inhibit the binding between SP-D an
222  Indeed, removal of fucose on myelin reduced DC-SIGN-dependent homeostatic control, and resulted in i
223           Finally, we show that, by reducing DC-SIGN in the cellular membrane, miR-155 is involved in
224 through a similar pathway to IVIG, requiring DC-SIGN, STAT6 signaling, and FcgammaRIIB.
225 y stimulation of IL-33 production that seems DC-SIGN independent.
226 an H. pylori carriers exhibited a semimature DC-SIGN(+)HLA-DR(hi)CD80(lo)CD86(lo) phenotype.
227                                      Several DC-SIGN-binding proteins show reactivity in serum IgE im
228 1-grabbing nonintegrin; CD209) and DC-SIGNR (DC-SIGN-related receptor, also known as L-SIGN and vario
229 Intriguingly, our data showed that silencing DC-SIGN on DCs promotes a Th2 phenotype in DC/T cell co-
230           Mechanistically, that simultaneous DC-SIGN engagement by fucosylated ligands and TLR4 signa
231                               In this study, DC-SIGN dynamics in microdomains were explored with seve
232 uced interleukin-4 production and subsequent DC-SIGN expression in this cell population.
233                            Thus, MV subverts DC-SIGN to control RLR activation and escape antiviral r
234                            Infection of T1H6-DC-SIGN cells with HHV-8 induces expression of beta-gala
235 infective dose (TCID50) assay using the T1H6-DC-SIGN cell line.
236  mutant molecule with K270W and a C-terminal DC-SIGN CRD subdomain transmitted HIV-1.
237 immune system differently from CRP, and that DC-SIGN is a target for antifibrotics.
238 ingle particle tracking, we demonstrate that DC-SIGN intrinsic nanoclustering strictly depends on its
239          Fluorescence imaging indicated that DC-SIGN microdomains may contain other C-type lectins an
240                         Blink indicates that DC-SIGN, another CTL (CD206), and influenza hemagglutini
241                    Although it is known that DC-SIGN organizes in nanoclusters at the surface of DCs,
242          We estimate, as a lower limit, that DC-SIGN and HA nanodomains contain on average two tetram
243  the QD surface mannose valency reveals that DC-SIGN binds more efficiently to densely packed mannosi
244           In the present study, we show that DC-SIGN, a C-type lectin expressed on DCs, binds directl
245                  We have recently shown that DC-SIGN, a C-type lectin first identified on dendritic c
246                      These data suggest that DC-SIGN structural elements distinct from the oligosacch
247  receptors on DCs and strongly suggests that DC-SIGN plays a critical role in HTLV-1 binding, transmi
248  conferred to L-SIGN chimeras containing the DC-SIGN CRD.
249 onfirmed that the minor fimbria contains the DC-SIGN-targeting carbohydrates fucose (1.35 nmol/mg), m
250                 We identified Trp-258 in the DC-SIGN CRD to be essential for HIV-1 transmission.
251 himeras demonstrated that replacement of the DC-SIGN carbohydrate-recognition domain (CRD) with that
252  no competition against known ligands of the DC-SIGN CRD.
253                                  Most of the DC-SIGN ligands studied previously are mannose- or fucos
254  and reduced transcriptional activity of the DC-SIGN promoter, which is likely to be the basis for it
255 for the complete extracellular region of the DC-SIGN tetramer was similar for all antibody glycoforms
256 SF1-dependent development, or preventing the DC-SIGN signaling pathway abrogated tolerance.
257 y reduce neutrophil influx via targeting the DC-SIGN murine homolog SIGN-related 1.
258 ay contain other C-type lectins and that the DC-SIGN cytoplasmic region is not required for microdoma
259  DC differentiation and function through the DC-SIGN-mediated induction of cell-signaling pathways.
260 rotein capable of selectively binding to the DC-SIGN protein.
261 ocyte-derived dendritic cells (MDDC) through DC-SIGN, resulting in nonproductive infection.
262 nner leaflet lipids are able to move through DC-SIGN microdomains.
263                                Antibodies to DC-SIGN, a c-type lectin selectively expressed by macrop
264 ctivation of human DCs by LPS via binding to DC-SIGN and MMR-1, leading to attenuated TLR signaling.
265 of gp120 also exhibited decreased binding to DC-SIGN in the context of native envelope spikes on a vi
266                                MV binding to DC-SIGN leads to activation of the kinase Raf-1, which i
267                                   Binding to DC-SIGN on MoDCs is followed by the internalization of P
268 id (aa) 196 and E1 aa 139 mediate binding to DC-SIGN, which supports the results of a previous report
269 action, were not required for C1q binding to DC-SIGN.
270 ts, chickpea, and corn, showed no binding to DC-SIGN.
271 GN with mannan, suggesting that C1q binds to DC-SIGN at its principal Ca(2+)-binding pocket, which ha
272              Mannosylated scFv also bound to DC-SIGN on the surface of dendritic cells.
273 m as neither recombinant Fc nor sFc bound to DC-SIGN.
274 C1q and the globular portion of C1q bound to DC-SIGN.
275 as confirmed by binding of soluble BTN2A1 to DC-SIGN-transfectants and its inhibition by a specific A
276 tion confers broader binding capabilities to DC-SIGN.
277  stability of DC-SIGNR tetramers compared to DC-SIGN.
278 herapy does not involve binding of IgG Fc to DC-SIGN and that alternative cell-surface lectins are re
279 d the binding of highly sialylated IgG Fc to DC-SIGN-expressing myeloid cells.
280 ferentially deliver the PSCA antigen gene to DC-SIGN-expressing 293T cells and bone marrow-derived DC
281 the binding of HIV envelope protein gp120 to DC-SIGN at nanomolar concentrations.
282 he entry of HHV-8 into B cells is related to DC-SIGN-mediated endocytosis.
283 er full-length nor cytoplasmically truncated DC-SIGN in microdomains appreciably exchanged with like
284  complex to high mannose, these vectors used DC-SIGN as their receptor.
285 control monoclonal antibody or delivered via DC-SIGN, another lectin receptor.
286 ficant mobility within microdomains, whereas DC-SIGN does not.
287                            In summary, while DC-SIGN can bind to a flexible combination of N-glycans
288 y revealed that C1q and gC1qR associate with DC-SIGN on blood DC precursors and immature DCs.
289  and was significantly reduced in cells with DC-SIGN knockdown.
290 est that allergens are able to interact with DC-SIGN and induce tumor necrosis factor-alpha expressio
291  whether our targeting vectors interact with DC-SIGN, which traps many types of viruses and gene ther
292 ound that these vectors do not interact with DC-SIGN.
293  non-IgE-binding proteins that interact with DC-SIGN; these proteins may be important for regulating
294 her fucosylation and better interaction with DC-SIGN [DC-specific intercellular adhesion molecule-3 (
295                        The interactions with DC-SIGN demonstrated the significance of alpha(1-6)manna
296 study that Y. pestis directly interacts with DC-SIGN and invades both DCs and alveolar macrophages.
297           We conclude that ES interacts with DC-SIGN to subvert the host immune responses by disarmin
298                  The interaction of MOG with DC-SIGN in the context of simultaneous TLR4 activation r
299  that, rather than being densely packed with DC-SIGN proteins, an elemental substructure exists.
300 ell in response to select microbes, yielding DC-SIGN(+) cells with critical functions of DCs.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top